Mobilizing Community Hypertension Access Pilot
ConditionHypertension
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRush University Medical Center
About this trial
The Live Healthy Chicago (LHC) Community Pilot is a prospective, community-based study evaluating the feasibility, effectiveness, and economic impact of a pharmacist-led hypertension management program delivered in trusted community settings on the West and South Sides of Chicago. Adults with uncontrolled hypertension will be identified and enrolled through community-based organizations, where a mobile clinical team-including community health workers, a pharmacist, and a registered nurse-will provide blood pressure screening, medication management, health education, and care coordination over a 3-month period. The study will assess participant engagement and acceptability, changes in systolic blood pressure. This pilot aims to address disparities in hypertension control by improving access to care in underserved communities and informing scalable, community-based models of chronic disease management.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults 18 years or older
Record of two blood pressure readings of SBP>130 on two separate occasions (days) within the past 3 months
Disqualifiers
Person is receiving dialysis
Person has had a heart or kidney transplant
Person is pregnant
Trial design
Design model
Single group
Treatments tested in this trial
Community-Based Multidisciplinary Hypertension Management Program
BehavioralA 12-week community-based hypertension management intervention delivered in community settings. The program includes pharmacist-led medication management under collaborative practice agreement, RN-led clinical monitoring and follow-up, and CHW-led outreach, education, and care navigation. Participants receive blood pressure screening, medication titration when indicated, home blood pressure monitoring support, and linkage to primary care and social services.
Treatment groups
200 Participants
are divided into 1 treatment groupGroup A: Live Healthy Chicago InterventionExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in Systolic Blood Pressure (SBP)
Mean change in systolic blood pressure from baseline to 12-week follow-up among participants enrolled in the LHC intervention.
Time frame
Baseline to 3 months (12 weeks)Secondary outcomes
1
SBP Reduction ≥10 mmHg
Proportion of participants achieving ≥10 mmHg reduction in systolic blood pressure from baseline.
Time frame
12 weeks2
Blood Pressure Control
Proportion of participants achieving SBP \<130 mmHg at 3-month follow-up.
Time frame
12 weeks3
Medication Adherence
Change in medication adherence measured using the ARMS questionnaire.
Time frame
Baseline and 12 weeks4
Feasibility (Recruitment and Retention)
Enrollment rate, retention rate, and completion of 3-month follow-up.
Time frame
Through 12 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov